An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

dc.authoridMastanzade, Metban/0000-0002-2281-5978
dc.authoridSevindik, Omur Gokmen/0000-0001-9636-4113
dc.authoridmaral, senem/0000-0003-4766-1861
dc.authoridipek, yildiz/0000-0003-2952-2286
dc.authorwosidSalihoglu, Ayse/Y-8937-2018
dc.authorwosidMastanzade, Metban/AAE-3938-2020
dc.authorwosidKALAYOGLU BESİSİK, SEVGİ/HNO-9101-2023
dc.authorwosidSevindik, Omur Gokmen/AAD-5452-2021
dc.authorwosidmaral, senem/AAH-9926-2021
dc.authorwosidipek, yildiz/ACY-2160-2022
dc.contributor.authorSevindik, Omur Gokmen
dc.contributor.authorOzkurt, Zubeyde Nur
dc.contributor.authorBoga, Can
dc.contributor.authorBesisik, Sevgi Kalayoglu
dc.contributor.authorIpek, Yildiz
dc.contributor.authorGeduk, Ayfer
dc.contributor.authorHarmandali, Aybuke
dc.date.accessioned2024-06-12T11:22:25Z
dc.date.available2024-06-12T11:22:25Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 11-14, 2021 -- Atlanta, GAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Hematolen_US
dc.identifier.doi10.1182/blood-2021-150175
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.urihttps://doi.org/10.1182/blood-2021-150175
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25906
dc.identifier.volume138en_US
dc.identifier.wosWOS:000835740102199en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Hematologyen_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleAn Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapyen_US
dc.typeConference Objecten_US

Dosyalar